NP-0361

N/A

Report date: 2022/01/14 13:23:58

NME

Base Information

Drug NameNP-0361

Drug Alias NameNP-61NP 0361

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionAcetylcholinesterase inhibitorsBeta amyloid A4 protein modulators

TargetsAcetylcholinesteraseBeta amyloid A4 protein

Therapy Area/IndicationsAlzheimer Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesNoscira Sa

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesNoscira Sa

Active IndicationsN/A

Inactive IndicationsAlzheimer Disease

ATC CodeN/A